For Immediate Release
Contact: Lisa Finger, 919-933-2021,
lfinger@biosignia.com
BioSignia appoints Dr. T. Colin Campbell to Board of
Directors
October 7, 2011 -- BioSignia today announced the appointment of
company founder, Dr. T. Colin Campbell to BioSignia’s Board of
Directors. Hailed by the scientific community, Dr. Campbell’s
groundbreaking work demonstrated that understanding the long-term
impact of lifestyle choices is central to preventing chronic
disease. Motivated by his father's life's work, Nelson Campbell
joined with his father to lead the founding of BioSignia in 1996.
Their early objective was to create a statistical model that
assessed the future onset of chronic illness based on a unique
individual’s characteristics.
For more than forty years, Dr. T. Colin Campbell has been at the
forefront of nutrition research. His legacy, the China Project, is
the most comprehensive study of health and nutrition ever conducted.
Dr. Campbell is the Jacob Gould Schurman Professor Emeritus of
Nutritional Biochemistry at Cornell University. He has more than
seventy grant-years of peer-reviewed research funding and authored
more than 300 research papers and coauthor of the bestselling the
book, The China Study: Startling Implications for Diet, Weight Loss
and Long-term Health.
|
|
|
